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Abstract 
Pregnant women living in malaria endemic areas are at high risk of developing severe 
infection that can lead to abortion, preterm delivery, intrauterine growth restrictions and 
foetal and maternal mortality. Plasmodium, the causing agent of malaria, infects erythrocytes 
that sequester in the placenta by interaction of Plasmodium specific proteins to receptors 
expressed on trophoblasts (placental cells). Placental response to infection is characterized 
by an exacerbated proinflammatory response, coagulopathy and fibrin accumulation, linking 
placental pathology to microcirculatory defects. This hostile environment impacts foetal 
development and viability. In vivo studies suggest that trophoblasts might respond to 
vasoactive factors leading to vasoconstriction or vasodilation. In fact, angiogenic and 
vasodilatory factors are expressed in trophoblasts; these molecules have a critical role in the 
maintenance of local homeostasis and normotension in uteroplacental perfusion. 
Unpublished results from our group showed that mRNA levels of bradykinin-receptor 2 (B2R) 
gene (Bdkrb2) among other vasoactive factors were downregulated at late gestation in mice 
infected with P. berghei compared to non-infected animals. Additionally, kininogen levels 
were also reduced in the peripheral blood and placentas of infected mice. We hypothesized 
that infection modulates B2R expression in trophoblasts leading to impaired signaling and to 
vasoconstriction of maternal blood spaces. Using an established placental malaria (PM) 
mouse model, we assessed percentage and surface expression of B2R on trophoblasts at 
late gestation (gestational day 18) and on primary trophoblasts co-cultured with 
Plasmodium-IEs (infected erythrocytes). The in vitro system was set as follows: trophoblasts 
were incubated with P. berghei-IEs or NIEs (non-infected erythrocytes) for 2 hours. In other 
conditions, trophoblasts were kept in culture for an additional period of 2 hours with medium 
only after incubation with IEs. The percentage of B2R+ trophoblasts was increased in a 
subpopulation of trophoblasts in G18 placentas from P. berghei-infected mice. B2R 
expression levels were reduced after 2 hours of incubation with IEs, an effect that seems to 
be maintained for an additional period of 2 hours. Furthermore, an increase in the 
percentage of cells expressing B2R was only observed after the additional 2-hour period of 
culture. Our results strongly suggest that Plasmodium infection is capable of modulating 
expression of B2R. This effect might impact the downstream signaling leading to insufficient 
vasodilation and possibly impaired placental perfusion, which can affect foetal growth and 
survival. 
Keywords: placental malaria, trophoblast, vasodilation, bradykinin, B2R 
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Resumo 
A malária é uma doença que afecta um elevado número de indivíduos em todo o mundo. 
Todos os anos, milhares de pessoas são diagnosticadas como infectadas, das quais uma 
grande maioria sucumbe à doença. Durante os últimos anos, grandes esforços têm sido 
feitos para reduzir a prevalência e incidência da doença, no entanto, o número de casos é 
ainda alarmante. A grande maioria dos casos ocorre na África sub-Sahariana, onde a 
mortalidade é elevada, principalmente entre as crianças, podendo também estender-se aos 
adultos. Os infectados desenvolvem sintomas bastante severos como anemia aguda, 
complicações respiratórias e malária cerebral, muitas vezes resultando na morte do 
hospedeiro. Nestes países subdesenvolvidos, as mulheres grávidas pertencem a um grupo 
de risco sendo altamente susceptíveis à doença e, quando infectadas, podem desenvolver 
um vasto leque de sintomas desde anemia severa a complicações no crescimento 
intrauterino. Todos estes sintomas levam a complicações no desenvolvimento fetal, 
resultando numa elevada taxa de abortos e nascimentos precoces o que terá, futuramente, 
um impacto na longevidade da criança devido ao reduzido peso e aos problemas no 
desenvolvimento. 
A doença é causada por um protozoário do género Plasmodium, injectado na circulação do 
hospedeiro quando um mosquito infectado (vector) do género Anopheles toma uma 
alimentação de sangue. Os esporozoítos, após entrarem em circulação, viajam rapidamente 
para o fígado onde vão desenvolver-se e multiplicar-se, naquela que é conhecida como a 
fase não sintomática da doença. Depois de 8 a 12 dias de maturação e multiplicação dentro 
dos hepatócitos, os parasitas (merozoítos) são libertados em circulação, infectando 
eritrócitos, iniciando assim a fase sintomática da doença. Na fase eritrocitária, o parasita 
continua a multiplicar-se e a maturar atingindo o estadio de esquizonte que, devido ao seu 
elevado número, vai promover a lise dos eritrócitos, com libertação dos merozoítos em 
circulação, capazes de infectar novos eritrócitos. Alguns parasitas diferenciam-se em 
gametócitos que são colectados por mosquitos, onde vão realizar a fase sexuada 
completando, posteriormente, o ciclo de vida. Dentro dos eritrócitos, o parasita é capaz de 
promover a expressão dos seus antigénios na superfície da célula, sendo muitos deles 
responsáveis por promover a adesão dos eritrócitos infectados ao endotélio vascular e ao 
tecido de vários órgãos, num processo designado por sequestração (sequestration). Estes 
mecanismos de adesão são um factor de virulência do parasita que permitem que este 
consiga evitar o sistema imunitário e a remoção pelo baço. 
Durante a gravidez, a placenta constitui um nicho favorável para a acumulação do parasita, 
que é capaz de aderir aos trofoblastos (células da placenta de origem fetal). P. falciparum 
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(estirpe de Plasmodium mais virulenta em humanos) liga-se a um glicosaminoglicano, 
nomeadamente o sulfato de condroitina A, existente em receptores expressos na placenta, 
por intermédio de uma proteína de adesão designada por var2CSA. A acumulação de 
parasita na placenta leva à produção de quimiocinas e citocinas pro-inflamatórias que vão 
levar ao recrutamento de células do sistema imunitário para o local da infecção. A 
coagulopatia, deposição de fibrina e supressão da sua degradação, em conjunto com o 
perfil pro-inflamatório vão contribuir para a patologia placentária, promovendo defeitos na 
microcirculação e no transporte de nutrientes que terão impacto no desenvolvimento e 
crescimento fetal. 
A placenta é um órgão fundamental cujo desenvolvimento e função devem ser preservados. 
Este órgão é responsável pelas trocas de gases e nutrientes entre a mãe e o feto, 
conferindo ainda tolerância contra o sistema imunitário materno e protecção física e 
imunológica contra patogénios, assegurando a sobrevivênvia e o desenvolvimento do feto. 
A grande maioria das complicações que podem ocorrer na gravidez resultam de 
insuficiência placentária causada por defeitos na vascularização da placenta que podem 
levar ao reduzido fluxo de sangue que terá futuras consequências no desenvolvimento fetal. 
Um trabalho publicado pelo laboratório (de Moraes et al., 2013) mostrou que os trofoblastos 
são capazes de controlar o fluxo sanguíneo abrindo e fechando espaços de circulação 
materna sugerindo que estas células provavelmente serão capazes de responder a factores 
de vasomodulação. Um grande número de trabalhos reportou que os trofoblastos, embora 
não tendo uma origem vascular, expressam um enorme reportório de factores ligados à 
angiogénese e à vasomodulação, os quais têm um profundo impacto na placentação, 
mantendo a homeostasia e a pressão sanguínea normalizada na perfusão utero-placentária. 
Tendo em conta que a desregulação destes factores leva a um fluxo sanguíneo insuficiente 
que terá consequências no desenrolar da gravidez, formulámos a hipótese de que a 
infecção causada pelo parasita terá impacto na regulação da expressão destes factores. 
Trabalhos anteriores mostraram que os níveis de mRNA do gene Bdkrb2 (gene do receptor 
da bradicinina 2, B2R) e do gene Nos3 (sintetase de óxido nítrico endotelial, eNOS) estão 
reduzidos em placentas infectadas, assim como os níveis de quininogéneo (precursor da 
bradicinina) sugerindo que a infecção afecta mecanismos de vasomodulação ligados à via 
de sinalização do B2R pela bradicinina.  
Os factores quantificados pertencem ao sistema das calicreinas-quininas (kallikrein-kinin 
system, KKS), um sistema de sinalização celular pleiotrópico. As quininas (como é o caso 
da bradicinina), contêm actividade bioquímica exercida após ligação ao seu receptor. Este 
tipo de sinalização pode resultar num vasto tipo de respostas desde vasodilatação e 
permeabilização vascular à resposta inflamatória. As quininas, geradas a partir da 
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conversão proteolítica do quininogéneo por uma quininase designanda por calicreina, vão 
exercer determinadas funções biológicas consoante o tipo de receptor a que se ligam. São 
conhecidos dois receptores associados a esta cascata de sinalização: o receptor do tipo 1 
(B1R), cuja expressão é induzida em resposta a alterações do sistema imunitário, 
participando na resposta inflamatória e na sensação de dor; e um receptor do tipo 2 (B2R), 
expresso constitutivamente em muitos tipos celulares (maioritariamente em células 
endoteliais) que, quando activado, promove vasodilatação, permeabilidade vascular e 
impede a agregação de plaquetas. O B2R, após activação, induz a mobilização de cálcio 
intracelular que promove a activada da sintetase de óxido nítrico endotelial, produtora de 
óxido nítrico, um potente vasodilator, exercendo o relaxamento do músculo liso levando ao 
aumento da vasodilatação e consequente redução da pressão sanguínea (hipotensão). Este 
factores foram mencionados como tendo a expressão aumentada durante a gravidez, 
sugerindo a importância da vasodilatação durante o decorrer da gestação. Também a 
expressão das enzimas e receptores constituintes desta via, foi documentada como estando 
desregulada nos trofoblastos em doenças em que ocorrem complicações na gravidez. 
Defeitos na sinalização via B2R podem promover vasocontrição e oclusão dos espaços de 
circulação materna na placenta, explicando o reduzido fluxo sanguíneo, a insuficiêcia 
placentária e as restrições no desenvolvimento fetal. 
De modo a testar esta hipótese, utilizámos um modelo animal (murganho) de malária 
placentária para avaliar os níveis de expressão do B2R em trofoblastos isolados de 
placentas infectadas com P. berghei. A expressão do receptor não foi significativamente 
alterada em trofoblastos isolados no final da gestação. Verificámos, um aumento 
significativo na expressão do B2R numa subpopulação de trofoblastos que, naturalmente, já 
expressava níveis consideráveis do receptor. Tendo em conta que, na placenta, uma 
enorme quantidade de factores maternos, fetais e do parasita podem afectar os níveis de 
expressão do receptor, crescemos e purificámos, em cultura, trofoblastos isolados de 
placentas não infectadas que foram, posteriormente, inoculados com eritrócitos infectados 
com parasita. As condições de cultura foram as seguintes: trofoblastos co-cultivados com 
eritrócitos não infectados ou infectados com P. berghei durante duas horas; adicionalmente, 
para avaliar se a presença do parasita é necessária para induzir a modulação do B2R, 
criámos outra condição experimental em que as células, após serem infectadas, foram 
incubadas com meio por um período adicional de duas horas. Estas duas horas de 
incubação com o parasita foram suficientes para reduzir os níveis de expressão do B2R, o 
efeito que parece ser prolongado até duas horas após remoção dos eritrócitos infectados. O 
aumento do número de células a expressar o receptor apenas foi observado durante o 
período de incubação adicional sem parasita. Os nossos resultados sugerem que a 
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presença do Plasmodium leva à modulação do B2R e que este efeito pode ter 
consequências na vasomodulação dos espaços de circulação materna na placenta, 
reduzindo a vasodilatação, consequentemente promovendo a redução do fluxo sanguíneo, 
a insuficiência placentária e o reduzido desenvolvimento fetal. 
Palavras-chave:  malária placentária. trofoblastos, vasodilatação, bradicinina, B2R 
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Introduction 
Malaria epidemiology and biology 
Malaria is a disease that affects a concerning number of people worldwide. Despite the 
tremendous progress made on reducing diseases’ incidence and prevalence, up to 214 
million cases were reported last year. In sub-Saharan Africa, malaria is the fourth highest 
cause of death in children under 5 years but the disease also affects adults and especially 
pregnant women (WHO, 2015). The disease has a high prevalence in children (Eijk et al., 
2015), which are prone to develop severe symptoms from the infection such as severe 
anaemia, metabolic acidosis, respiratory distress and cerebral malaria (Miller et al., 2002). 
The disease is caused by a protozoan parasite from the gender Plasmodium, from which P. 
falciparum and P. vivax are associated to the more severe pathological cases in humans. 
Parasite is transmitted when an infected female mosquito from the gender Anopheles takes 
a blood meal from a mammalian host (Fig. 1). After being injected subcutaneously, 
sporozoites travel through the blood to rapidly invade the hepatocytes in the liver, where 
they develop and multiply into thousands of merozoites (Prudêncio et al., 2006). Abrupt 
increase in merozoite numbers will eventually lead to hepatocyte rupture with parasite 
release into circulation, beginning a systemic infection with the onset of the first symptoms. 
When in circulation, merozoites are capable of invading erythrocytes relying on their highly 
variable surface receptors to mediate binding (Miller et al., 2002). Once inside erythrocytes, 
the parasite changes the surface protein repertoire of the cell by expressing its own proteins 
at the membrane. P. falciparum erythrocyte membrane protein 1 (PfEMP1) is a protein with 
variable surface antigens (VSA) encoded by an extended var gene family that mediates 
adhesion of the infected erythrocytes (IEs) to the vasculature and brain endothelium, as well 
as to the placenta in pregnant women (Ho and White, 1999). This leads to a local 
accumulation of IEs in a process known as sequestration, which promotes a set of 
conditions that allows maturation and multiplication of the parasite. In addition, this 
phenomenon has an impact also in IE survival since it avoids parasite clearance by the 
spleen (Engwerda et al., 2005). Once it reaches late stage, the fully mature parasite 
(schizont) leaves the cell due to erythrocyte lysis releasing merozoites, which are capable of 
engaging circulatory erythrocytes. Gametocytes, that are responsible for ensuring the sexual 
stage of the life cycle inside the mosquito, are also released from erythrocytes upon lysis, 
becoming available to be collected by the invertebrate host to fulfill the cycle. Inside the 
mammalian host, the accumulation of IEs can happen in several tissues as previously 
mentioned (Ho and White, 1999). Accumulation in the brain (cerebral malaria) and in the 
placenta (placental malaria) (Fig. 1) may lead to the more severe pathological outcomes of 
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the disease, triggering an exacerbated immunological response that not only contributes to 
the disease control, rather contributing to the fatalities (Schofield and Grau, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Plasmodium life cycle and pathological outcomes. Upon taking a blood meal, the infected 
Anopheles injects the sporozoites into circulation that rapidly travel to the liver. Hepatocytes fulfil their 
nutritional needs and give them shelter until they become fully developed and mature. Maturity results in the 
burst of hepatocytes and release of merozoites into circulation, which infect erythrocytes, maturing into 
gametocytes and late stage schizonts. Erythrocytes invasion lead to the onset of the first symptoms and 
sequestration in the brain and placenta result in pathologies as cerebral malaria (CM) and placental malaria 
(PM), respectively (Schofield and Grau, 2005). 
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Placental-malaria (PM) 
In sub-Saharan Africa approximately 28 million pregnant women are exposed to malaria and 
are at high risk of developing placental malaria (WHO, 2015). Amongst other factors, 
susceptibility to infection during pregnancy is highly associated to the placenta, which 
constitutes a suitable niche for parasite accumulation. The adhesion of P. falciparum-IEs is 
mediated by a variation of the PfEMP1 protein known as var2CSA (Salanti et al., 2003) that 
promotes the interaction between the IEs and the glycosaminoglycan chondroitin sulfate A 
(CSA) (Fried and Duffy, 1996), which is expressed in syncytiotrophoblasts (placental cells). 
This process of IE sequestration is the leading cause of poor pregnancy outcomes. Abortion, 
preterm delivery and intrauterine growth restrictions (IUGR) will affect newborn’s longevity, 
which generally have low birth weight (LBW) upon delivery (Desai et al., 2007). 
Major consequences of Plasmodium infection in the placenta are inflammation and impaired 
microcirculation. Infection induces trophoblasts (foetal-derived placental cells) to produce 
chemokines, which will act as chemoattractants for proinflammatory cells (Lucchi et al., 
2008, 2011; Walter et al., 1982) that are recruited to the site of infection. Proinflammatory 
cytokines such as IFN-γ (interferon- γ) and TNF-α (tumor necrosis factor α) are secreted 
(Fried et al., 1998) and these were shown to be linked to placental microcirculatory defects 
and foetal loss. Knockout mice for IFN-γ had delayed foetal death yet, sustained TNF-α 
production was shown to induce placental disruption and excessive coagulation (Poovassery 
et al., 2009). Additionally, infection leads to high fibrin deposition and fibrinolysis resistance 
(Avery et al., 2012). Together, the cytokine-driven coagulopathy and antifibrinolytic state 
affect placental microcirculation leading to foetal growth restrictions (FGR). Moreover, the 
complement pathway molecule C5a, a regulator of inflammatory and immune response, was 
also shown to be linked to FGR; C5a was shown to be upregulated in PM, affecting 
angiogenesis and, consequently, foetal development (Conroy et al., 2013). Besides 
microcirculatory defects it has been suggested that inflammation might also impact 
metabolic pathways, affecting foetal development. Inflammation in the placenta has been 
shown to reduce the expression of some amino acid transporters (Boeuf et al., 2013), 
glucose transport isoform 1 (GLUT-1) (Chandrasiri et al., 2014) and lipid and hormone 
transporters (Lybbert et al., 2016), which are critical for foetal growth. Additionally, disruption 
of other metabolic pathways, namely iron homeostasis, might also contribute to increased 
foetal death in PM (Penha-Gonçalves et al., 2014).  
Despite current knowledge on PM pathology, more studies are needed to fully understand 
this disease and for that, animal models are essential tools that should be explored. Mouse 
models for the study of PM remain controversial due to the lack of molecular homology 
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between mouse and human strains of Plasmodium (Hviid et al., 2010). However, PM models 
have been shown to recapitulate several aspects of human PM; infection of BALB/c mice at 
mid-stage pregnancy with P. berghei impacts foetal development and viability (Neres et al., 
2008).  P. berghei pre-immune mice showed less severe pathology and were protected after 
multiple gestations – a model that reproduces features of women living in high malaria 
endemic areas (Marinho et al., 2009). Several parasite strains where shown to be capable of 
inducing placental pathology in mice. Infection of C57Bl/6 pregnant mice with P. berghei 
strains that do not induced cerebral malaria (CM) in B6 mice such as NK65, K173, PM4KO 
(Rodrigues-Duarte et al., 2012) lead to severe placental pathology suggesting different 
mechanisms underlying pathology between CM and PM. Moreover, P. chabaudi infection at 
earlier gestational stage (G10) induces abortion by IFN-γ and TNF-α-driven coagulopathy 
(Poovassery and Moore, 2009). Recently our lab has developed a var2CSA-based PM 
model induced by a transgenic P. berghei expressing var2CSA (de Moraes et al., 2016). 
This model is a tool for in vivo pre-clinical studies to understand var2CSA-mediated 
pathology. These models will give a tremendous contribution to the understanding of PM 
pathology, foetal and placental abnormalities.  
 
Placental Development and Function 
It is imperative to ensure placental development and function, which is critical for the survival 
and proper development of the foetus. Placenta has a vast role of function guarantying 
nutrients and gas exchanges (Lager and Powell, 2012), tolerance against maternal immune 
system (Kanellopoulos-Langevin et al., 2003) and protection against pathogens (Robbins 
and Bakardjiev, 2012). 
Two structurally and functionally distinct units compose this highly complexed and 
specialized organ: the chorionic plate, constituted by foetally derived villi, which contain the 
physical structures that separate foetal compartment from maternal blood spaces, and the 
basal plate that is constituted by the uterine wall that separates placental microenvironment 
from maternal decidua and myometrium. In humans (Gude et al., 2004) (Fig. 2b), the 
chorionic villi are branched extension of the foetal chorion mainly composed by a very 
particular type of foetally derived cells known as trophoblasts. The villi have protrusions that 
increase the area of contact with the maternal blood, turning physiological exchanges more 
effective, and those are surround by a multicellular layer called the placental membrane. 
This membrane is the physical barrier that separates foetal from maternal compartments. It 
is constituted by a multinucleated layer of syncytiotrophoblast (STB) that mediates all the 
physiological processes that were previously mentioned. Below it, a layer of mononuclear 
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cytotrophoblast (CTB) can be used to replace syncytium or to promote the anchoring of the 
villi to the decidua after undergoing a phenotypic change to extravillous cytotrophoblast 
(EVT). In the core of these chorionic villi, extensive networks of foetal capillary surrounded 
by endothelium receive nutrients and oxygen transported by trophoblasts, delivering foetal 
waste products to be secreted into the maternal circulation. At the anchoring villi, CTBs and 
STBs ensure the attachment of the villi to the uterine wall and the phenotypic switch of the 
CTBs to EVTs make them capable of invading and remodeling the uterine spiral arteries. 
Therefore, these cells, after replacing maternal endothelium, they become responsible for 
controlling placental perfusion by modulation blood flow. 
Mice have functionally identical but structurally distinct placentas when comparing with 
humans (Rossant and Cross, 2001) (Fig. 2a). Mice placentas are arranged in a structure 
called the labyrinth, which is different from the human chorionic villi. Nonetheless, both are 
comparable in terms of some cellular populations regarding their features. Early in placental 
development, trophoblast giant cells (TGCs) acquire an early invasive phenotype that is 
analogous to the one from EVTs in humans. Invasion and implantation takes place followed 
by a replacement of maternal endometrium by the chorionallantoic structure that results from 
fusogenic events between chorion and allantois. Arising from the chorion, two layers of STB 
and mononuclear trophoblastic cells cover the foetal vasculature that rises from the allantois 
as it happens in humans. Eroded endometrium is replaced by trophoblasts, which surround 
maternal sinuses (Adamson et al., 2002) canalizing maternal blood across the placenta. 
Mononuclear trophoblastic cells are in direct contact with the maternal blood but their 
functions are still unknown.  
Both placental types are haemochorial (Wildman et al., 2006), which means that chorion-
derived structures are in direct contact with the blood that is freely circulating in the maternal 
blood spaces. Despite the structural differences between human and mouse placentas, the 
similarities between trophoblast populations, the haemochorial structure and hemotrophic 
nutrition, make the rodent model a very useful tool in the study of placental diseases, being 
always mindful of how careful one must be regarding the extrapolations that can be made 
from one model to the other (Malassiné et al., 2003). 
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Figure 2. Comparative anatomy of the mouse and human placenta: structural and cellular 
comparison. a) Mouse placenta. Structure of the labyrinth and detailed view of maternal-foetal interface. 
Bilayer of syncytiotrophoblast (STBs) surrounding maternal sinus separating maternal blood from foetal 
capillary. Mononuclear trophoblastic cells of unknown function in direct contact with the maternal blood. b) 
Human placenta. Chorionic villi are the main structures in human placenta. Detailed picture show the villous 
surrounded by a monolayer of STB containing cytotrophoblasts (CTB) beaned it. This membrane separates 
maternal blood that bathe the villous from foetal vessels. (Rossant and Cross, 2001).  
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Plasmodium infection impact on vasoactive factors 
As previously mentioned, trophoblasts are in direct contact with the maternal blood, being 
responsible for the regulation of blood flow, canalizing the blood into maternal blood spaces. 
Previous works, using an established placental malaria mouse model have shown that 
trophoblasts are capable of actively modulate the blood flow in the placenta, rearranging 
compartments by “opening and closing” maternal blood spaces (de Moraes et al., 2013). 
These findings suggest that trophoblasts might respond to vasomodulatory factors leading to 
vasoconstriction or vasodilation of maternal sinuses. It is known that trophoblasts express a 
vast repertoire of angiogenic and vasomodulatory factors that have a critical role in 
placentation, maintaining local homeostasis and normotension in uteroplacental perfusion 
(Valdes et al., 2009). Previous studies in our lab (unpublished) showed dysregulation of the 
mRNA levels of expression of vasomodulatory factors such as the bradykinin-receptor 2 
gene (Bdkrb2, B2R) (Fig. 3A, B and E) and endothelial nitric oxide synthase (Nos3, eNOS) 
(Fig. 3C, D and F) during infection. In non-infected mice (NI), placental Bdkrb2 transcript 
levels increased throughout late gestation (Fig. 3A) whereas in infected (INF) ones Bdkrb2 
levels were modulated from gestational day 16 (G16) onwards and significantly decreased at 
G18. (Fig. 3B). Yet, when comparing the mRNA levels between INF and NI placentas for the 
different time-points, we observed a marked downregulation at G18 (Fig. 3E). The levels of 
Nos3 mRNA also increased progressively from G16 onwards in NI placentas (Fig. 3C) 
whereas in INF placentas no alterations were observed from G16 to G18 (Fig. 3D). In 
comparisons between INF and NI placentas, Nos3 mRNA levels were downregulated from 
G17 onwards (Fig. 3F). Additionally, kininogen levels were decreased in the context of 
infection both in the peripheral blood (Fig. 3G) and in placental extracts (Fig. 3H), as well as 
nitric oxide levels (data not shown). These components, which expression and production 
were altered during infection are members of the bradykinin-signaling pathway that was 
shown to be linked to vasodilation and are dysregulated in complicated prengancies 
(Corthorn et al., 2006). As such we hypothesized that infection might impair the transduction 
signaling through the bradykinin-signaling pathway leading to placenta insufficiency and poor 
pregnancy outcomes.  
 
 
 
8 
 
 
 
 
 
Figure 3. Plasmodium infection induces dysregulation of Bdkrb2, Nos3 mRNA levels and kininogen 
levels. Pregnant mice infected at G13 were euthanized at different time-points (G16-G18) from which 
placentas were removed for RNA extraction and quantification of the mRNA levels of the Bdkrb2 (B2R) gene 
(A, B and E) and Nos 3 (eNOS) gene (C, D and F) by qPCR. Fold change to G16 of the mRNA levels of the 
Bdkrb2 gene in A) non-infected (NI) and B) infected (INF) placentas. Fold change to G16 of the mRNA levels 
of the Nos3 gene in C) NI and D) INF placentas. E) Fold change of the mRNA levels of the Bdkrb2 gene 
normalized to NI. F) Fold change of the mRNA levels of the Nos3 gene normalized to NI. Additionally, 
kininogen levels were measured in G) maternal serum and H) placental extracts in NI and INF mice using 
competition ELISA. * p<0.05, ** p<0.01, *** p<0.001; line refer to mean. 
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The bradykinin-signaling pathway 
The bradykinin-signaling pathway belongs to the pleiotropic kallikrein-kinin system (KKS). 
This complex network is responsible for triggering a broad spectrum of cellular and 
physiological responses after ligand binding to the respective receptor, being involved in 
vasomodulation, vascular permeability, inflammation and pain (Bhoola et al., 1992). Briefly, 
all kinin peptides (i.e. bradykinin) are converted from a kininogen precursor (HK) that is 
cleaved into active kinins by the action of a peptidase known as kallikrein, which acts freely 
in the plasma or in the tissue (Fig. 4). Kinins induce their pleiotropic effects via activation of 
two known receptors: the type 1 (B1R) and the type 2 (B2R), that belong to a family of G 
protein-coupled receptors (GPCR) (Leeb-Lundberg et al., 2005), which are differentially 
expressed across the tissue. The B1R has minimal or null expression, which is induced in 
response to injuries and inflammation (Calixto et al., 2004). In contrast, B2R is constitutively 
expressed, being predominant in endothelium but less expressed in the smooth muscle 
(Figueroa et al., 2001). This receptor is expressed mainly at the cell surface but also has 
cytosolic and nuclear distribution due to internalization and cytosolic/nuclear trafficking 
(Takano and Matsuyama, 2014). As depicted in Fig. 4, bradykinin (BK), the most important 
and functionally active kinin, binds to the B2R inducing vasodilation by promoting the release 
of nitric oxide (NO) (Drummond and Cocks, 1995) by endothelial nitric oxide synthase 
(eNOS) (Knowles and Moncada, 1994) and the production prostaglandins (PGs) (Cherry et 
al., 1982). It was previously reported that HK (Brann et al., 2011) and NO (Conrad et al., 
1993) production increases during pregnancy suggesting a contribution to maternal 
vasodilation. Additionally, elements of this signaling cascade, namely B2R and eNOS were 
shown to be expressed in the placenta (endothelial cells and trophoblasts), and 
dysregulation was shown to be linked to pathologies with complicated pregnancies as it 
happens in pre-eclampsia (Corthorn et al., 2006). This disease of unknown cause is related 
to placental malaria in a way that recapitulates some pathological outcomes caused by the 
parasite namely foetal growth restriction, hypertension and foetal and maternal mortality 
(Sibai et al., 2005). 
Therefore, our previous unpublished data together with published reports support the 
hypothesis that Plasmodium infection might affect the bradykinin-signaling pathway leading 
to microcirculatory defects in the placenta and consequent foetal growth restriction. The 
present study focused on the evaluation of the expression levels of bradykinin-receptor 2 
(B2R) on trophoblasts during infection. As such, we aimed at:  
1. Ex vivo approach: Expression of B2R was assessed on trophoblasts isolated from 
infected placentas at G18. The choice for this time-point is based on features 
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previously observed: reduction of foetal weight, high values of parasitemia and 
downregulation of the vasoactive factors;  
2. In vitro approach: B2R levels were evaluated on trophoblasts co-cultured with P. 
berghei-IEs in vitro. Results will help clarify if IEs interaction with trophoblasts leads 
to modulation of the B2R expression.   
 
 
 
 
 
Figure 4. The bradykinin-signaling pathway. Kininogen (HK) is converted in the plasma or in the tissue by 
kallikrein into active kinins. Bradykinin (BK) is the most important kinin, mediating several physiological 
processes throw the activation of the bradykinin-receptor 2 (B2R). Activation of this receptor promotes 
vascular permeability and avoids platelet aggregation. Additionally, it induces cytosolic calcium (Ca2+) 
mobilization that stabilizes endothelial nitric oxide synthase (eNOS) activity. The following nitric oxide (NO) 
production, together with prostaglandins (PGs), will induce vascular relaxation and vasodilation.  
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Materials and Methods 
Animals and parasites 
Eight week-old BALB/c females and C57Bl/6 males were obtained from the animal facility at 
the Instituto Gulbenkian de Ciência. Mice were bred and maintained under specific-pathogen 
free (SPF) conditions. Plasmodium berghei ANKA (Pb-ANKA) parasite constitutively 
expressing green fluorescent protein (GFP) under the control of the eef1 promoter (15cyl 
clone) (Janse et al., 2006) was used for all in vitro and in vivo experiments. For parasite 
expansion, infected-erythrocytes (IEs) from frozen vials were intraperitoneally (i.p.) injected 
in BALB/c mice and used when parasitemia reached 5-10% measured by GFP detection 
using flow cytometry. All procedures involving laboratory mice were in accordance with 
national (Portaria 1005/92) and European regulations (European Directive 86/609/CEE) on 
animal experimentation and were approved by the Instituto Gulbenkian de Ciência Ethics 
Committee and the Direcção-Geral de Veterinária (Official National Entity for regulation 
laboratory animals usage).   
 
Pregnancy mouse model 
BALB/c females were mated to C57Bl/6 males (2:1; female: male ratio) and separated in the 
next day. Females were weighed upon separation considering that day as the gestational 
day 1 (G1). Females were monitored and a weight gain of 4 – 5 g at G13 was taken as an 
indicative of pregnancy. Pregnant mice were used for experimental infection or for the 
isolation and culture of primary trophoblasts. Breedings from this allogenic model give litters 
with a high number of pups having small variations of weight between them. 
Experimental design for evaluation of B2R expression 
Ex vivo approach. At G13, females were intravenously (i.v.) infected with 106 IEs of the 
previously expanded parasite. Weight gain and parasitemia were monitored from G17 to 
G18. Infected and non-infected pregnant mice were euthanized at G18 from which placentas 
were collected for trophoblast isolation. Trophoblasts were stained for flow cytometry (FACS) 
analysis to assess isolates’ purity, by targeting cytokeratin 7 (KRT7) trophoblast marker, and 
bradykinin receptor 2 (B2R) surface expression.  
In vitro approach. Primary trophoblasts were isolated at G18 and were either co-cultured 
with Pb-IEs or non-infected erythrocytes (NIEs) after 6-7 days of enrichment. Trophoblasts 
were removed from culture, stained with anti-KRT7 and anti-B2R fluorescent antibodies and 
analyzed by FACS. 
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Primary trophoblast isolation  
Primary trophoblasts were isolated as described elsewhere (adapted from Pennington et al., 
2012). Briefly, pregnant mice were euthanized at G18 by CO2 narcosis and the uterus was 
carefully removed. Placentas from foetuses with similar weight between them were 
separated and pooled in groups. After dissection, placentas were coarsely minced inside a 
petri dish using a proper blade and transferred to a tube containing 1 mg/mL of collagenase 
IA (Sigma-Aldrich) and 4 U/µL DNase diluted in 25 mL of DMEM medium (Biowest) 
previously supplemented with 20 mM HEPES (Gibco) and 0.35 g/L sodium bicarbonate 
(Gibco) (wash buffer). Incubation was done at 37 ºC water bath for 30 – 40 minutes with 
vigorous pipetting every 10 minutes to digest the minced placentas. Macerated tissue was 
passed through a 70 µm strainer and washed at 400 x g for 10 minutes at 4 ºC. Cells were 
then added to a Percoll (Sigma-Aldrich) gradient made as described elsewhere (Nagamatsu 
et al., 2004). Pelleted cells were resuspended in 4 mL of 25% Percoll, being gently layered 
on the top of 4 mL of 40% Percoll contained inside a 15 mL tube. These layers were done by 
diluting, in wash buffer, a 90% Percoll solution previously prepared with PBS 10x. 2 mL of 
PBS 1x was added to the top of the 25% layer, followed by a centrifugation of 800 x g for 20 
minutes at 4 ºC (without brake). Cells disposed on the interface between the two Percoll 
layers were collected, washed with PBS 1x and treated with ACK (ammonium-chloride-
potassium buffer) for 5 minutes to lyse erythrocytes. Cells were washed, counted and plated 
in 24-well plate at a density of 2 x 105 cells/well. Cells were cultured in DMEM complete 
medium containing 10% FBS (Gibco), 1% HEPES (Gibco), 1% sodium pyruvate (Gibco), 1% 
penicilin and streptomicin (Gibco), 1% non-essential amino acids (BioWhittaker), 1% 
glutamine, 0.1% β-mercaptoethanol (Gibco) and 0.1% gentamicin (Sigma). Cells were 
cultured for 1 week for enrichment of trophoblasts and washed every other day to remove 
non-adherent cells.  
Parasite synchronization 
P. berghei-IEs were synchronized as described elsewhere (Janse et al., 2006) to obtain late 
stage schizont. Briefly, IEs were expanded in non-pregnant BALB/c mice during 
approximately one week reaching a parasitemia between 5 – 10%. Infected mice were 
sacrificed and immediately bleed by cardiac puncture using heparin to avoid clothing. 
Collected blood was transferred to a tube containing approximately 5 mL of RPMI (Gibco) 
supplemented with 20% FBS (Gibco) and 0.1% neomycin (Sigma-Aldrich) (synchronization 
medium) and centrifuged at 450 x g for 8 minutes. Pelleted erythrocytes were resuspended 
in 50 mL of synchronization medium and transferred to a 75 cm2 flask followed by the 
addition of a mixture of gas containing 5% CO2, 5% O2 and 90% N2 for 90 seconds at a 1.5 – 
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2 bar pressure. IEs were incubated overnight in a shaking incubator set for 50 rpm at 36.5 
ºC. On next day, in the morning (approximately 18 hours after incubation), IEs-containing 
schizonts were sorted by passing suspension throw a 25 LS column using magnetic-
associated cell sorting (MACS) technique. Column was washed with PBS 1x and cell 
suspension was passed throw it directly from the flask. Column was washed 6 times with 
PBS 1x and IEs were eluted using DMEM complete medium. Cells were washed at 450 x g 
for 8 minutes to pellet the IEs-containing schizont and then resuspended in complete culture 
medium for counting and further use.              
In vitro assays  
A number of 2 x 105 synchronized Pb-IEs or NIEs were added to trophoblast cultures (1:1 
ratio; erythrocytes-trophoblasts). NIEs used as a control were freshly collected from the tail 
of a non-infected mouse and centrifuged at 500 x g for 5 minutes to remove any plasma 
component that could influence the response of cultured trophoblasts. Pelleted NIEs were 
resuspended in complete medium, counted, and added to cultures. Experiments were 
conducted using different conditions: 1) Trophoblasts were incubated with IEs/NIEs for a 
period of 2h; 2) Trophoblasts were cultured with IEs/NIEs for 2h, washed with ACK to 
remove non-phagocytosed IEs/NIEs and then incubated with complete medium for an 
additional period of 2h. After incubation period, trophoblasts were detached from wells with 
100 µL of Accutase (eBioscience) for 15 – 20 minutes at 37 ºC. Complete medium was 
added to neutralize the Accutase activity and cells were then aspirated to a FACS plate and 
stained with fluorescent antibody markers for KRT7 and B2R. 
Flow Cytometry 
Primary trophoblasts freshly isolated or detached from culture plates were stained to assess 
purity and the expression of the B2R by flow cytometry. Stainings were performed in FACS 
96-well plates with U-shaped bottom and between 2 – 4 x 105 cells were used per staining 
condition. Cells were firstly incubated with 100 µL of Fc Block (2.4G2 ab specific for FcII/III) 
diluted in PBS 1x containing 2% FBS and 0.1% sodium azide (NaN3) (FACS buffer) for 15 
minutes at 4 ºC and then washed at 550 x g for 1 minute at 4 ºC. Pelleted cells were 
incubated with 50 µL of the anti-B2R Cy5 antibody (1:100) (Bioss Antibodies) for 30 minutes 
at 4 ºC. Cells were washed 2 times and resuspended in 100 µL of Fixation/Permeabilization 
solution (BD Biosciences) for 20 minutes at 4 ºC. Fixed cells were washed 2 times with 
Perm/Wash solution 1x (BioLegend), which kept them permeable for intracellular staining. 
After washing, cells were incubated with 50 µL of Perm/Wash 1x containing the anti-KRT7 
(cytokeratin 7) PE antibody (1 µg per 2 – 4 x 105 cells) (Santa Cruz Biotechnology) for 30 
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minutes at 4 ºC. Ultimately, cells were washed 2 times with Perm/Wash 1x and then with 
FACS buffer prior to cytometry analysis. Cells were resuspended in 100 – 400 µL of FACS 
buffer and acquired using the LSR Fortessa X-20 cytometer (BD Biosciences). Specific 
combinations laser (nm) - filter were used to detect the different fluorescence: 561 nm - 
586/15E to detect PE, 640 nm – 640/30 to detect Cy5 and 488 nm – 530/30 to identify 
autofluorescent events. 
Statistical Analysis 
Data are displayed as scattered dot-plot with line at mean (normal distribution) or median 
(non-normal distribution), or as single dots representing mean ± SD. Unpaired T test and 
Mann-Whitney test were performed using GraphPad Prism 6.0 software. Comparisons 
between data with probability value of p<0.05 were considered significant. 
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Results 
Characterization of the placental malaria mouse model 
In our placental malaria mouse model (Fig. 5A) mice with confirmed pregnancies at G13 
were infected with 106 P. berghei-IEs. Maternal weight gain and parasitemia were monitored 
during the following days until G18, when mice were euthanized for trophoblast isolation. 
Maternal weight increases throughout pregnancy and weight gain at late gestation (from G17 
to G18) reflects that phenomenon. Non-infected mice gain an average of 7.467 ± 0.416 g at 
G17 and 10.133 ± 1.301 g at G18, approximately gaining 3 g within this 24-hour window 
(Fig. 5D). This increase in maternal weight is lost in infected pregnant mice, which showed 
null weight gain between G17 (5.025 ± 1.028 g) and G18 (5.725 ± 2.1 g). Parasitemia (Fig. 
5B and 5C) was measured at late gestation, 4-5 days post-infection (d.p.i.). Signs of parasite 
expansion were seen at the fourth d.p.i. (G17) with mice having an average parasitemia of 
16.5 ± 2.421 % (Fig. 5B). After 24 hours (G18), parasitemia recorded had approximately a 2-
fold increase (Fig. 5C) to values averaging 32.9 ± 4.120 % (Fig. 5B). Pups taken upon 
caesarean were weighed to assess the impact of infection on their growth (Fig. 5E). Weight 
of foetuses from infected mothers was significantly decreased (0.74 ± 0.108 g) when 
compared to the ones that went through a normal pregnancy (0.875 ± 0.0.089 g) (p<0.0001). 
Together these results show the infection impact on foetal development, reproducing the 
pregnancy outcome features previously established. These data suggest that growth 
restrictions might be consequence of placental insufficiency caused by IEs sequestration, 
which is probably the cause of increase in maternal parasitemia. 
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Figure 5. Placental malaria mouse model. A) Schematic diagram of the gestation model, starting at G1 
after mating, followed by i.v. infection with 10
6 
Pb-IEs upon pregnancy confirmation at G13; maternal weight 
and parasitemia were monitored until trophoblast isolation at G18. B) Maternal parasitemia expressed as 
percentage (%) of infected erythrocytes and C) G18 parasitemia fold increase to G17. D) Maternal weight 
gain in non-infected (NI) and infected (INF) mice between G17 and G18 (normalized by the number of 
foetuses). E) Foetal weight measured after caesarean of NI and INF mice. **** p<0.0001 (Unpaired T test); 
line refer to mean. 
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Impact of Plasmodium infection on B2R expression by trophoblasts in vivo 
We observed an increase in parasitemia levels from G17 to G18, null variation on the 
maternal weight gain towards G18 and a reduction of foetal weight in infected pregnant mice 
(Fig. 5). This late time-point gathers particular characteristics of the model that may be an 
indicative of impaired placental homeostasis and function. This might be the best time 
window to look at the impact that infection has on the expression of vasoactive factors 
namely the bradykinin-receptor 2 (B2R). Modulation of B2R expression could suggest 
impaired signaling and function of the associated pathway. To confirm if the levels of the 
receptor are modulated by infection, we assessed the surface expression of the B2R in 
trophoblasts isolated at G18 from non-infected (NI) and infected (INF) mice. Freshly isolated 
trophoblasts were stained and analysed by flow cytometry. Depicted gating strategy (Fig. 
6A) shows the selection of events with cellular morphology (FSC-A x SSC-A) from which 
very few doublets were excluded (FSC-A x Pulse Width). Trophoblasts were identified as the 
events positive for cytokeratin 7 (KRT7), a specific marker for this cell type. KRT7+ events 
were analysed for B2R expression by gating the events that were positive for Cy5 (Autofluor-
FITC x B2R-Cy5). Parameter labelled as “530/530” was used as an empty channel to sort 
out autofluorescent events that were KRT7 negative (KRT7-). The percentage (%) of 
trophoblasts was significantly reduced (p=0.027) in infected samples (median of 72.7% in NI 
to 59.9% in INF) (Fig. 6C), suggesting that infection might be inducing death of the 
trophoblasts. No variation was observed neither in the overall percentage of trophoblasts 
expressing B2R (Fig. 6D) nor in the levels of expression of the receptor (median 
fluorescence intensity, MFI) (Fig. 6E). Additionally, it was possible to separate trophoblasts 
with different levels of B2R expression. Gating strategy illustration (Fig. 6B) shows the 
identification of the trophoblast populations with low (KRT+B2RLow), intermediate 
(KRT+B2RInt) and high (KRT+B2RHigh) expression of the receptor. Populations were 
distributed in an unequal frequency (Fig. 6F); KRT+B2RLow is the most abundant population, 
followed by KRT+B2RInt and then by KRT+B2RHigh. Population that expresses high levels of 
B2R (KRT+B2RHigh) was the only one showing a significant increase (p=0.014) in frequency 
during infection (Fig. 6F). In opposition, no variation was seen between these populations 
regarding B2R levels of expression (Fig. 6G). Taken together, the increase in percentage of 
the KRT7+B2RHigh population may be an indicative of receptor’s de novo synthesis and/or 
upregulation of the expression by mobilizing intracellular receptors to the membrane as it 
was previously shown to occur in some cell types (Takano and Matsuyama, 2014). 
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Figure 6. Impact of Plasmodium infection on trophoblasts B2R expression in vivo. A) Schematic 
representation of the gating strategy. Cells were gated (FSC-A x SSC-A) and doublets were excluded (FSC-
A x Pulse Width). Events positives for KRT7 (KRT7
+
) (KRT7-PE x 530/530) were identified as trophoblasts 
and B2R expression was evaluated (KRT7
+
B2R
+
) (B2R-Cy5 x 530/530). B) Identification of three populations 
of trophoblasts with differentially expression of B2R: 1 - B2R
Low
, 2 - B2R
Int
, 3 - B2R
High
. C) Frequency (%) of 
KRT7
+
 events (trophoblasts) and D) trophoblasts-expressing B2R (KRT7
+
B2R
+
). E) B2R expression by 
trophoblasts plotted as median fluorescence intensity (MFI). F) Frequency (%) and G) expression (MFI) of 
the different populations of trophoblasts-expressing B2R. Comparisons were done between trophoblasts from 
non-infected (NI) and infected (INF) placentas for the different parameters. * p<0.05 (Mann-Whitney test); line 
refer to median. 
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Plasmodium infection modulates B2R levels of expression in vitro 
Evidences suggest that Plasmodium infection influences B2R expression by trophoblasts in 
our in vivo model (Fig. 6). Infection of trophoblasts in vitro allows to attribute any modulation 
on the B2R levels of expression to the presence of P. berghei-IEs since there is no other 
systemic factor that could interfere with the B2R expression. To evaluate if B2R modulation 
could be a consequence of the interaction with infected erythrocytes (IEs), we generated an 
in vitro model (Fig. 7A) where primary trophoblasts were cultured with IEs or non-infected 
erythrocytes (NIEs) for 2 hours. The choice for a 2-hour culture was based on our previous 
experimental set-up. We cultured trophoblasts with IEs or NIEs for 1 hour and 2 hours. Both 
conditions induced reduction of B2R expression on infected trophoblasts (compared to NIEs) 
but fold change was higher at 2-hour incubation compared to the 1-hour time-point (data not 
shown). Percentages of B2R+ trophoblasts were not altered in none of the two conditions. 
After incubation period, non-phagocytosed IEs or NIEs were removed with ACK, 
trophoblasts were detached from plates, stained with anti-KRT7 and anti-B2R fluorescent 
antibodies and analysed by flow cytometry. Figure 7B illustrates the gating strategy used to 
evaluate B2R expression on cultured trophoblasts. Cells were identified by morphology 
(FSC-A x SSC-A) followed by doublets exclusion (FSC-A x Pulse Width). Trophoblasts were 
identified as positive events for the KRT7 marker (KRT7+) while removing autofluorescent 
events using the 530/30 filter (KRT7-PE x 530/530). Finally, trophoblasts expressing B2R 
were identified inside the double positive quadrant (KRT7+B2R+) were frequency and median 
fluorescence intensity were measured. Our data showed that IEs do not significantly alter the 
frequency of trophoblasts expressing B2R after 2 hours of infection (Fig. 7C). On the other 
hand, it was observed an impact on B2R expression levels (Fig. 7D); IEs lead to a significant 
decrease of the MFI (p=0.0128). These results support the idea that IEs contact with 
trophoblasts might have direct consequences on the expression of B2R. 
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Figure 7. Plasmodium infection alters B2R levels of expression in vitro. A) Experimental design. 
Isolated trophoblasts were plated and enriched for 6-7 days for infection with synchronized schizonts (IEs). 
Non-infected erythrocytes (NIEs) were added as control. After 2 (h)ours, cells were detached from plate and 
stained for KRT7 and B2R. B2R expression was measured by flow cytometry. B) Schematic representation 
of the gating strategy. Cells were gated (FSC-A x SSC-A) and doublets were excluded (FSC-A x Pulse 
Width). Events positives for KRT7 (KRT7+) (KRT7-PE x 530/530) were identified as trophoblasts and B2R 
expression was evaluated (KRT7+B2R+) (B2R-Cy5 x KRT7-PE). C) Frequency and D) MFI of B2R expression 
in trophoblasts co-cultured with IEs or NIEs for 2h. Comparisons were done by normalizing data from IEs to 
NIEs. * p<0.05 (Mann-Whitney Test); line refer to median. 
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Acute Plasmodium infection lead to a prolonged modulation of B2R 
expression  
We have observed that 2-hour incubation with P. berghei-IEs leads to reduction of 
expression levels of B2R on trophoblasts (Fig. 7D). To understand if the constant presence 
of IEs is needed to induce a modulatory phenotype we incubated primary trophoblasts with 
IEs or NIEs for 2 hours, removed non-phagocytosed IEs with ACK and then incubated 
trophoblast with complete medium (Ø) for an additional 2 hour period (Fig. 8A). Trophoblasts 
incubated with NIEs were submitted to the same conditions. IEs lead to a significant 
increase of the percentage of trophoblasts expressing B2R in the subsequent incubation 
period (p=0.0207) (Fig. 8B), yet the expression levels were not significantly altered 
(p=0.2786) (Fig. 8C) when comparing to non-infected control. This apparent reduction of the 
MFI levels after the additional incubation period suggests that the constant presence of the 
parasite is not needed to induce a prolonged downregulation of B2R. Moreover, by 
comparing the levels of expression between cells incubated for the additional 2-hour period 
after IEs exposure to conditions without the extra period (only submitted to IEs), we 
observed that the MFI levels are maintained (Fig. 8E). These results suggest that the 
downregulatory effect induced by infection might be prolonged throughout time 
independently of the presence of the parasite. We also observed an increase frequency of 
trophoblasts expressing B2R induced during the additional 2-hour period of culture without 
IEs (p=0.0003) (Fig 8D).  Regarding non-infected cultures, no differences were observed 
neither in the frequency of trophoblasts-expressing B2R (Fig. 8D) nor in the expression 
levels (Fig. 8E). Together these results suggest that B2R modulation in infected cultures 
occurs due to interaction between parasite and trophoblasts. Additionally, the percentage of 
trophoblasts expressing B2R increases, which is in line with our in vivo studies. 
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Figure 8. Plasmodium infection leads to a prolonged modulation of B2R expression in vitro. A) 
Experimental design. Isolated trophoblasts were plated and enriched for 6-7 days for infection with 
synchronized schizonts (IEs). Non-infected erythrocytes (NIEs) were added as control. After 2 (h)ours, cells 
were washed with ACK to remove non-phagocytosed erythrocytes and incubated with medium (Ø) for an 
additional period of 2h (+). Cells were detached from plate and stained for KRT7 and B2R. B2R expression 
was measured by flow cytometry. B) Frequency and C) MFI of B2R expression in trophoblasts co-cultured 
with IEs or NIEs for 2h with further incubation with medium (Ø) for 2h (+). Data from IEs were normalized to 
NIEs. D) Frequency and E) MFI of B2R expression in trophoblasts co-cultured with IEs or NIEs for 2h, 
additionally incubated with medium (Ø) for another 2h (+). Data from IEs and NIEs (+) were normalized to the 
controls that went only through a 2h incubation with IEs or NIEs (-), respectively. Comparisons were done by 
normalizing test conditions to their internal controls. * p<0.05, *** p<0.001 (Mann-Whitney test); line refer to 
median. 
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Discussion 
In the present study, we show that P. berghei infection can modulate the expression of 
bradykinin-receptor 2 (B2R) on trophoblasts. Using a well-established PM mouse model, we 
looked at B2R expression on late gestation (G18). We observed three distinct populations 
regarding the levels of B2R expression and that the percentage of B2R+ cells were 
increased in the B2RHigh subpopulation compared to non-infected mice. We also show that in 
vitro P. berghei-IEs induced modulation of B2R expression levels after 2-hour incubation 
with IEs. Yet, no changes were observed in the percentage of cells expressing B2R on the 
first 2-hour incubation with IEs. However, frequency of trophoblasts expressing B2R 
increased after the additional 2-hour incubation period without IEs. Altogether, these results 
suggest that modulation of the B2R expression might occur due to direct interaction between 
IEs and trophoblasts.  
The bradykinin-signaling pathway exerts its functional effects mainly through the activation of 
B2R upon bradykinin binding inducing vasomodulation and vascular permeability (Leeb-
Lundberg et al., 2005). We hypothesized that impaired signaling through B2R may lead to 
impaired vasodilation and control of placental perfusion, which can have an impact on foetal 
weight gain and survival. As such, we assessed B2R surface expression on trophoblasts 
isolated from non-infected and infected pregnant mice euthanized at G18. Expression was 
evaluated at this late time-point for different reasons: 1) high values of parasitemia were 
reached at this time-point; 2) a significant decrease in foetal weight was observed 
specifically at G18 and 3) downregulation of the B2R gene was only observed at G18. Using 
flow cytometry, we identified trophoblasts as positive events for the cytokeratin 7 marker 
(KRT7+) (Maldonado-Estrada et al., 2004). Placentas infected with Plasmodium had a 
significant reduction in the percentage of trophoblasts suggesting cell death caused by 
infection. After identification of three subpopulations of trophoblasts with different levels of 
B2R expression, we observed that the subpopulation with high levels of expression 
(KRT7+B2RHigh) was increased during infection. It is possible that increase in percentage of 
B2R+ trophoblast during infection is reflecting the upregulation of the Bdkrb2 gene at G17 
supporting de novo synthesis. On the other hand, it is possible that the exposure of the B2R 
at the surface does not depend on de novo synthesis (since the mRNA levels are decreased 
at G18) but on the intracellular distribution of the receptor, which can be recycled to the 
membrane (Takano and Matsuyama, 2014). Stainings were performed on trophoblasts from 
pooled placentas due to technical restrictions: it is not possible to isolate a sufficient amount 
of cells from individual placentas to perform proper stainings. Taking this into account, it is 
possible that these conditions masked a possible differential expression of the receptor 
between infected placentas that could have different degrees of infection. 
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Our data on evaluation of B2R surface expression on G18, together with the unpublished 
previous work that shows downregulation of the mRNA levels of Bdkrb2 gene at the same 
time-point, support the idea that the parasite is capable of modulating B2R expression. To 
clarify this, primary trophoblasts isolated from non-infected placentas were co-cultured with 
P. berghei-IEs. This in vitro system does not include systemic factors that may be influencing 
B2R expression in vivo. Trophoblasts incubated with parasite for 2 hours showed a decrease 
on B2R levels of expression but no significant changes were observed regarding the 
percentage of cells expressing the receptor. Yet, a significant increase in the frequency of 
trophoblasts expressing B2R was observed after an additional 2-hour incubation period with 
medium. The impact on the levels of expression seemed to be maintained after this period 
since the MFI levels were 1) decreased when comparing with the non-infected control that 
had the additional incubation period, although not significantly and 2) maintained when 
comparing to the infected control only stimulated for 2 hours. No changes were observed in 
uninfected conditions. Since IEs and NIEs were lysed with ACK before the second 
incubation, it is possible that trophoblasts suffered a prolonged modulation of the receptor 
without being in the constant presence of the parasite. B2R activation upon BK binding is 
known to cause downregulation, redistribution and internalization of the receptor (Takano 
and Matsuyama, 2014). These dynamics are known to be dependent of phosphorylation and 
dephosphorylation events (Blaukat et al., 1996) on the serine and threonine residues of the 
C-terminal tail of the receptor (Pizard et al., 1999), reducing the levels of available B2R at 
the cell surface. In our in vitro experiments, we observed downregulation of B2R expression 
levels after IEs infection. It is possible that contact between parasite and trophoblasts may 
trigger cytosolic kinases’ activity promoting phosphorylation of intracellular proteins leading 
to internalization of B2R as previously described (Takano and Matsuyama, 2014). Similar 
events were shown to occur in syncytiotrophoblast and in BeWo cell line where P. 
falciparum-IEs were capable of inducing phosphorylation of tyrosine residues of cytosolic 
proteins (Lucchi et al., 2006).  
We observed that downregulation of B2R was followed by an increase in the percentage of 
trophoblasts expressing the receptor after 4 hours in culture in which the first 2 hours were 
incubated with IEs. Although we have not assessed underlying mechanisms to explain the 
increase of B2R+ cells, we speculate that this response could be consequence of 
proinflammatory cytokine secretion by trophoblasts after IE contact. It has already been 
shown that Plasmodium induces the production of proinflammatory cytokines namely IFN-γ 
(interferon- γ) and TNF-α (tumor necrosis factor α) by the placenta during pregnancy (Fried 
et al., 1998). Poovassery and co-workers showed that TNF-α was secreted by cultured cells 
isolated from the ectoplacental cone (murine trophoblasts) after exposure to IEs 
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(Poovassery and Moore, 2009). Additionally, we observed that TNF-α transcription was 
induced in primary murine trophoblasts after incubation with P. berghei-IEs (unpublished 
data). In our model it is also possible that factors produced by the parasite such as 
hemozoin contribute to the TNF-α production, as previously reported in a model of primary 
human syncytiotrophoblast  (Lucchi et al., 2011). These proinflammatory factors have been 
associated to the upregulation of B2R expression (Haddad et al., 2000; Lung et al., 1998). 
As such, it is possible that in our system IEs infection could induce the production of TNF-α 
and other cytokines by trophoblasts leading to an increase in the percentage of trophoblasts 
expressing B2R if we assume that regulation occurs at the level of the de novo synthesis. To 
further understand if the upregulation of B2R in our in vitro system is a consequence of de 
novo synthesis or receptor recycling (Takano and Matsuyama, 2014), it will be imperative to 
inhibit de novo synthesis. Future experiments should be conducted with cycloheximide, 
inhibiting protein synthesis to confirm the existence of any cytosolic source of the receptor. 
Our previous unpublished results showed that normal pregnant mice have a gradual 
increase in kininogen (bradykinin precursor) levels in the peripheral blood throughout late 
gestation (from G16 to G18). This phenomenon was reported in studies in rats (Brann et al., 
2011), which showed an increase in kininogen levels during pregnancy and late gestation as 
a normal physiological behaviour. Pregnant mice infected with P. berghei had a significant 
decrease in peripheral kininogen levels across the same gestational time window possibly 
due to the activity of endogenous and/or parasitic factors. Published works during the 70s 
have shown that mice infected with P. berghei had increased kinin values (i.e. bradykinin) 
and reduced kininogen levels (Ohtomo and Katori, 1972), which could be explained by the 
increased activity of kallikrein, enzyme responsible for kininogen conversion into kinins, also 
reported in primates infected with P. knowlesi (Onabanjo and Maegraith, 1970). More 
recently, it was shown that both human and rodent strains of Plasmodium (P. falciparum and 
P. chabaudi, respectively) are capable of converting the kininogen precursor into active 
kinins by endogenous proteases (Bagnaresi et al., 2012). These parasitic enzymes together 
with host’s proteases activity might explain the reduction of kininogen levels. Kininogen 
quantification was done as an indirect measurement for active bradykinin due to technical 
issues imposed by the short lifetime of the bradykinin-like peptides that can also be 
degraded by other circulating enzymes like the angiotensin-converting enzyme (ACE) 
(Skidgel, 1992). As such, it is difficult to argue about availability of bradykinin and functional 
outcomes. Furthermore, no changes were observed in kininogen levels in non-infected 
placentas from G16 to G18 whereas infected placentas had a slight decrease in the levels of 
kininogen at G18, although not significant. It is possible that kininogen in the placenta might 
be subjected to the same parasitic and endogenous factors acting in the peripheral blood. As 
26 
 
such, reduction of the kininogen levels suggest that Plasmodium infection can affect the 
bradykinin-signaling pathway also at the level of the peptides that trigger the biological 
functions of this cascade. Regardless these evidences, it is not clear how kinins are linked to 
severe malaria and how defective levels of kininogen/kinins are connected to impaired 
placental function. 
Our previous data also showed reduction of the mRNA levels of the Bdkrb2 gene in infected 
placentas at late gestation. Preliminary results from our lab on primary trophoblasts 
incubated with increasing bradykinin concentrations showed increasing levels of the Bdkrb2 
transcript (data not shown) suggesting that gene regulation can be done by the B2R agonist 
in a dose-dependent manner. Additionally, similar evidences for the bradykinin-receptors 
self-regulation by their agonists was already described for different cell types, where kinins 
where capable of inducing gene transcription and modulation of surface receptors after 
binding (Guevara-Lora et al., 2009; Phagoo et al., 1999). These evidences support the idea 
that high levels of peripheral kininogen in normal pregnancies can be converted locally by 
tissue kallikrein expressed in the placenta (Corthorn et al., 2007; Valdes et al., 2001) into 
active kinins leading to the upregulation of the Bdkrb2 gene by the agonist. On the other 
hand, an increase in peripheral and placental kininogen levels was not observed in infected 
mice possible due to increased proteolysis promoted by infection as previously mentioned, 
into kinins capable of inducing gene transcription. This idea is supported by the upregulation 
of the gene seen at G16 and G17 by comparing gene expression between non-infected and 
infected placentas. Additionally, as previously discussed, Plasmodium infection might induce 
the production of proinflammatory cytokines such as IFN-γ and TNF-α (Fried et al., 1998), 
which are positive regulator of B2R transcription (Haddad et al., 2000; Lung et al., 1998) and 
have different roles in placental pathology and pregnancy outcomes (Poovassery et al., 
2009). These support the contribution of inflammation to B2R regulation and to the 
dysregulation of microcirculation. Nevertheless it is important to highlight that mRNA levels 
were quantified in total placental extracts (a mixture of trophoblasts and endothelial cells), 
therefore it is not possible to infer that gene modulation occurs mainly on trophoblasts, which 
are the focus of this study. However, it is plausible to say that a group of factors linked to the 
physiological and immunological machinery are regulating the bradykinin-signaling cascade 
interfering with the normal functioning of this system at different levels. 
Interestingly, mRNA levels of Nos3 (endothelial nitric oxide synthase, eNOS), as well as the 
nitrite levels (stable nitric oxide (NO) metabolite used as a proxy for NO concentrations) 
(data not shown) were also reduced in infected placentas in opposition to the increased 
levels observed in non-infected placentas. Downstream events after B2R activation by BK 
includes mobilization of intracellular calcium, stabilizing eNOS activity, leading to the 
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production of NO from L-arginine and L-homoarginine (Khalil et al., 2015), a pathway well 
described in endothelial cells (Knowles and Moncada, 1994). Although eNOS has been 
shown to be expressed in trophoblasts (Corthorn et al., 2006) it is not clear if BK-B2R 
pathway operates in the same manner in these cells leading to NO production. We 
hypothesized that during infection, insufficient activation of B2R results in reduced 
production of NO as well as reduced levels of Nos3 mRNA. In an attempt to assess NO 
production in vitro, we cultured primary trophoblasts with different concentration of BK; 
supernatants were collected for nitrite quantification. It was neither possible to quantify nitrite 
in the supernatants nor to detect Nos3 mRNA in our cultures suggesting that primary 
trophoblasts lacking systemic factors in vitro undergo differentiation, losing the expression of 
factors that would be normally expressed in vivo. As such, further experiments must be 
done, trying to quantify the levels of some of these by-products that are downstream of B2R 
activation such as prostaglandins. Measuring these secreted products after IEs incubation 
and BK stimulation would be the assay that would help to clarify any possible modulation of 
the B2R signaling pathway with an impact on the production of components with relevant 
biological function. 
We hypothesized that vasoactive factors are important for the modulation of circulation in the 
placenta, inducing trophoblasts to open-up and/or close maternal blood spaces (de Moraes 
et al., 2013). Therefore, it is possible that dysregulation of the signaling through B2R induces 
vasoconstriction due to the suppression of the downstream production of the vasodilators, 
namely NO (Drummond and Cocks, 1995) and prostaglandins (Cherry et al., 1982). 
Bradykinin and NO were also mentioned as important to avoid vascular clotting due to their 
properties regarding aggregation (Valdés and Corthorn, 2011). As such, insufficient B2R 
activation during infection might also contribute to clotting and coagulopathy, which are 
mechanisms involved in PM pathology. These events, together with vascular constriction, 
could explain the occlusion of the maternal blood spaces observed in P. berghei infected 
placenta (de Moraes et al., 2013). Blockade of B2R signaling was also shown to reduce 
foetal weight in guinea pigs (Valdés et al., 2014) and additionally, NO production was shown 
to be decreased during pre-eclampsia (Choi et al., 2002) a disease that shares some 
features with PM such as reduced blood flow and hypertension (Tannetta and Sargent, 
2013). These common characteristics support the idea that these phenotypic similarities 
might have an involvement of the bradykinin-signaling pathway in both diseases.  
Our study shows that Plasmodium is capable of modulating the expression levels of B2R on 
trophoblasts and that infection leads to an increase in the percentage of B2R+ trophoblasts. 
Whether these events are consequences of B2R recycling and/or de novo synthesis is still 
unclear. Future studies will also help clarify if modulation of B2R expression is a direct 
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consequence of IEs interaction with trophoblasts or if other components are involved such 
as proinflammatory cytokines, BK converting enzymes or other molecules relevant to this 
pathway. These results support the involvement of the bradykinin-signaling pathway in 
placental malaria pathology, which can be linked to placental insufficiency and poor 
pregnancy outcomes. 
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